Auflistung nach Autor:in "Rönnefahrt, Ines"

Gerade angezeigt 1 - 8 von 8

Das Europäische Arzneimittelrecht
(2014) Rönnefahrt, Ines
EU legislation - challenges and future perspectives of Environmental Risk Assessment (ERA)
(2013) Rönnefahrt, Ines
Human pharmaceutical substances
(2022) Gildemeister, Daniela; Hein, Arne; Brandt, Ute; Buck, Annika; Hickmann, Silke; Rönnefahrt, Ines
Improving environmental protection in EU pharmaceutical legislation
(Umweltbundesamt, 2022) Gildemeister, Daniela; Buck, Annika; Hein, Arne; Rönnefahrt, Ines; Ebert, Ina; Debiak, Malgorzata
In preparation of the revision of Directive 2001/83/ EC and Regulation (EC) No 726/2004, the German Environment Agency (UBA) proposes legal changes to reduce pharmaceutical residues in the environment. The proposals are based on UBA's experiences as competent authority for the environmental risk assessment (ERA) of pharmaceuticals. Our overall aim is to ensure a comprehensive risk management system without compromising availability of medicines for patients. In this context we consider the recent EU strategy on pharmaceuticals and initiatives in connection with EU`s Green Deal particularly the Zero Pollution Ambition and the one substance one assessment approach. Quelle: www.umweltbundesamt.de
Minimise harmful effects of pharmaceuticals on the environment : What are the objectives in the EU?*
(2022) Rönnefahrt, Ines; Buck, Annika; Gildemeister, Daniela
Monographs of Environmental Data for Active Substances in Veterinary Pharmaceuticals
(Umweltbundesamt, 2023) Rönnefahrt, Ines; Schmitz, Susanne; Ebert, Ina; Deutschland. Umweltbundesamt
This scientific opinion paper outlines existing problems related to data gaps, non-harmonized assessments, insufficient post-market control, and data transparency of pharmaceuticals, and identifies possible solutions through the introduction of a monograph system for active pharmaceutical substances. From UBA's point of view, monographs are the crucial bridge between risk assessment, risk communication and risk management and this across different regulatory areas. The current revision of the general pharmaceutical legislation of the EU offers the opportunity to establish a monograph system for active substances for both veterinary medicinal products and medicinal products for human use. Quelle: www.umweltbundesamt.de
Widening the European Green Deal's perspective towards a sustainable Europe
(Umweltbundesamt, 2021) Neßhöver, Carsten; Bannick, Claus Gerhard; Beckert, Barbara; Claussen, Ulrich; Doyle, Ulrike; Eckermann, Frauke; Frische, Tobias; Haße, Clemens; Günther, Jens; Hollweg, Beate; Huckestein, Burkhard; Janitzek, Timmo; Kabel, Claudia; Jering, Almut; Keßler, Hermann; Klatt, Anne; Knoche, Guido; Köder, Lea; Koller, Matthias; Krause, Bernd; Kreuser, Margarethe; Lindenthal, Alexandra; Löwe, Christian; Manstein, Christopher; Matthey, Astrid; Meurer, Doris; Mohaupt, Volker; Mutert, Tina; Obermaier, Nathan; Pieper, Silvia; Plickert, Sebastian; Rechenberg, Jörg; Reichart, Almut; Rönnefahrt, Ines; Schulte, Christoph; Schweitzer, Christian; Spengler, Laura; Stolzenberg, Hans-Christian; Suhr, Michael; Töpfer, Christoph; Unnerstall, Herwig; Deutschland. Umweltbundesamt
The European Green Deal, published by the European Commission in 2019, represents a new and ambitious approach to put environment and sustainability at the heart of European policy. Its ambitions are high, yet the planned measures might not be sufficient to actually meet them. The report analyzes the European Green Deal from the perspective of the German Environment Agency and places it in the context of the global challenge of achieving the United Nations' sustainable development goals. In addition to necessary measures in the thematic fields of the European Green Deal, the report also addresses the structural adjustments needed as key levers to achieve the desired goals. The report concludes that the European Green Deal is an important step forward, but that further efforts beyond those described there are still needed in order to achieve a sustainable Europe. Quelle: www.umweltbundesamt.de
Wie die EU Arzneimittel "grüner" machen will
(2021) Rönnefahrt, Ines; Ebert, Ina